Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Obstructive Lung Diseases

  Free Subscription


1 Allergy
7 Ann Allergy Asthma Immunol
1 Can Respir J
2 Chest
1 Clin Exp Allergy
12 Eur Respir J
4 J Allergy Clin Immunol
1 J Appl Physiol (1985)
4 J Asthma
3 J Investig Allergol Clin Immunol
3 N Engl J Med
3 Pediatr Pulmonol
4 PLoS One
1 Proc Natl Acad Sci U S A
13 Respir Med
10 Respir Res
1 Rev Mal Respir

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. CHANTVEERAWONG T, Sangkangjanavanich S, Chiewchalermsri C, Pradubpongsa P, et al
    Increased circulating CRTH2(+) Tregs are associated with asthma control and exacerbation.
    Allergy. 2021 Oct 22. doi: 10.1111/all.15145.
    PubMed         Abstract available

    Ann Allergy Asthma Immunol

  2. BALL L, Velasquez SA, Jammal OMA, White AA, et al
    Atypical Eosinophilic Granulomatosis with Polyangiitis with Spontaneous Aspirin Reactivity and IgE Mediated Anaphylaxis.
    Ann Allergy Asthma Immunol. 2021 Jul 14. pii: S1081-1206(21)00502.

  3. LAFORCE C, Chipps BE, Albers FC, Reilly L, et al
    Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: the TYREE study.
    Ann Allergy Asthma Immunol. 2021 Oct 23. pii: S1081-1206(21)01169.
    PubMed         Abstract available

  4. CARR TF
    Treatment approaches for the patient with T2 low asthma.
    Ann Allergy Asthma Immunol. 2021;127:530-535.
    PubMed         Abstract available

    Asthma, in quest of optimizing care.
    Ann Allergy Asthma Immunol. 2021;127:517.

  6. GRANT T, Croce E, Matsui E
    Asthma and the Social Determinants of Health.
    Ann Allergy Asthma Immunol. 2021 Oct 18. pii: S1081-1206(21)01132.
    PubMed         Abstract available

  7. MAGLIONE PJ, Gereige JD, Lee TK
    Consideration of pulmonary hypertension in the evaluation of common variable immunodeficiency.
    Ann Allergy Asthma Immunol. 2021;127:513.

  8. FINEMAN S, Lee G, Hernandez-Truillo V, Chipps BE, et al
    From the Pages of Allergy Watch.
    Ann Allergy Asthma Immunol. 2021 Jul 8. pii: S1081-1206(21)00490.


  9. FRIEDMAN JN, Davis T, Somaskanthan A, Ma A, et al
    Avoid doing chest x rays in infants with typical bronchiolitis.
    BMJ. 2021;375:e064132.

    Can Respir J

  10. DING Q, Wei X, Li J, Gao YZ, et al
    Role of the Emphysema Index Combined with the Chronic Obstructive Pulmonary Disease Assessment Test Score in the Evaluation of Chronic Obstructive Pulmonary Disease.
    Can Respir J. 2021;2021:9996305.
    PubMed         Abstract available


  11. SAFIRI S, Carson-Chahhoud K, Karamzad N, Sullman MJM, et al
    Prevalence, deaths and disability-adjusted-life-years (DALYs) due to asthma and its attributable risk factors in 204 countries and territories, 1990-2019.
    Chest. 2021 Oct 23. pii: S0012-3692(21)04206-9. doi: 10.1016/j.chest.2021.
    PubMed         Abstract available

  12. RUPANI H, Kent BD
    Using FeNO Measurement in Clinical Asthma Management.
    Chest. 2021 Oct 18. pii: S0012-3692(21)04109-X. doi: 10.1016/j.chest.2021.
    PubMed         Abstract available

    Clin Exp Allergy

  13. CAFFREY OSVALD E, Gong T, Lundholm C, Larsson H, et al
    Parental socioeconomic status and asthma in children - using a population-based cohort and family design.
    Clin Exp Allergy. 2021 Oct 22. doi: 10.1111/cea.14037.
    PubMed         Abstract available

    Eur Respir J

  14. LOUIS R, Louis G, Bonhomme O
    NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice.
    Eur Respir J. 2021;58.

  15. BAFADHEL M, Barnes N, Bourke SC, Compton C, et al
    A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial.
    Eur Respir J. 2021;58.

  16. WINSLOW S, Odqvist L, Diver S, Riise R, et al
    Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and Haemophilus infection in COPD.
    Eur Respir J. 2021;58.
    PubMed         Abstract available

  17. PHILIP J, Collins A, Smallwood N, Chang YK, et al
    Referral criteria to palliative care for patients with respiratory disease: a systematic review.
    Eur Respir J. 2021;58.
    PubMed         Abstract available

  18. PARK HY, Chang Y, Kang D, Hong YS, et al
    Blood eosinophil counts and the development of obstructive lung disease: the Kangbuk Samsung Health Study.
    Eur Respir J. 2021;58.
    PubMed         Abstract available

  19. PETOUSI N, Wooden A, Russell REK
    A new piece in the puzzle: the eosinophil and the development of COPD.
    Eur Respir J. 2021;58.

  20. KEIR HR, Chalmers JD
    IL-6 trans-signalling: how Haemophilus surfs the NET to amplify inflammation in COPD.
    Eur Respir J. 2021;58.

  21. PORSBJERG C, Maitland-van der Zee AH, Brusselle G, Canonica GW, et al
    3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD.
    Eur Respir J. 2021;58.

  22. SIBILA O, Laserna E, Shoemark A, Perea L, et al
    Heterogeneity of treatment response in bronchiectasis clinical trials.
    Eur Respir J. 2021 Oct 21. pii: 13993003.00777-2021.
    PubMed         Abstract available

  23. ELSEY L, Pantin T, Holmes LJ, Tavernier G, et al
    Outcomes over the first two years of treatment with mepolizumab in severe asthma.
    Eur Respir J. 2021 Oct 28. pii: 13993003.01313-2021.
    PubMed         Abstract available

  24. PIJNENBURG MW, Frey U, De Jongste JC, Saglani S, et al
    Childhood asthma- pathogenesis and phenotypes.
    Eur Respir J. 2021 Oct 28. pii: 13993003.00731-2021.
    PubMed         Abstract available

  25. CHANG AB, Boyd J, Bush A, Grimwood K, et al
    Children's Bronchiectasis Education Advocacy and Research Network (Child-BEAR-Net): an ERS Clinical Research Collaboration on improving outcomes of children and adolescents with bronchiectasis.
    Eur Respir J. 2021;58.

    J Allergy Clin Immunol

  26. PINKERTON JW, Kim RY, Brown AC, Rae BE, et al
    Relationship between type 2 cytokine and inflammasome responses in obesity-associated asthma.
    J Allergy Clin Immunol. 2021 Oct 19. pii: S0091-6749(21)01525.
    PubMed         Abstract available

  27. SKEVAKI C, Ngocho JS, Amour C, Schmid-Grendelmeier P, et al
    Epidemiology and management of asthma and atopic dermatitis in sub-Saharan Africa.
    J Allergy Clin Immunol. 2021 Oct 26. pii: S0091-6749(21)01631.
    PubMed         Abstract available

  28. REDMOND C, Akinoso-Imran AQ, Heaney LG, Sheikh A, et al
    Socioeconomic disparities in asthma healthcare utilization, exacerbations and mortality: A systematic review and meta-analysis.
    J Allergy Clin Immunol. 2021 Oct 18. pii: S0091-6749(21)01560.
    PubMed         Abstract available

  29. TJALVIN G, Svanes O, Igland J, Bertelsen RJ, et al
    Maternal preconception occupational exposure to cleaning products and disinfectants and offspring asthma.
    J Allergy Clin Immunol. 2021 Oct 11. pii: S0091-6749(21)01399.
    PubMed         Abstract available

    J Appl Physiol (1985)

  30. DE BRANDT J, Burtin C, Pomies P, Vandenabeele F, et al
    Carnosine, oxidative and carbonyl stress, antioxidants, and muscle fiber characteristics of quadriceps muscle of patients with COPD.
    J Appl Physiol (1985). 2021;131:1230-1240.
    PubMed         Abstract available

    J Asthma

  31. BRITTAN MS, Moss A, Watson JD, Federico MJ, et al
    Association between early childhood lower respiratory tract infections and subsequent asthma.
    J Asthma. 2021 Oct 27:1-16. doi: 10.1080/02770903.2021.1999469.
    PubMed         Abstract available

  32. ERTURK G, Gunday C, Evrendilek H, Sagir K, et al
    Effects of High Intensity Interval Training and Sprint Interval Training in Patients with Asthma: A Systematic Review.
    J Asthma. 2021 Oct 27:1-19. doi: 10.1080/02770903.2021.1999470.
    PubMed         Abstract available

  33. MOSNAIM GS, Stempel DA, Gonzalez C, Adams B, et al
    Electronic Medication Monitoring vs. Self-Reported Use of Inhaled Corticosteroids and Short-Acting Beta2-Agonists in Uncontrolled Asthma.
    J Asthma. 2021 Oct 26:1-6. doi: 10.1080/02770903.2021.1996600.
    PubMed         Abstract available

  34. VAN DEN BOSCH WB, Kloosterman SF, Andrinopoulou ER, Greidanus R, et al
    Small airways targeted treatment with smart nebulizer technology could improve severe asthma in children: a retrospective analysis.
    J Asthma. 2021 Oct 26:1-13. doi: 10.1080/02770903.2021.1996597.
    PubMed         Abstract available

    J Investig Allergol Clin Immunol

  35. PLAZA V, Giner J, Curto E, Alonso-Ortiz MB, et al
    Assessing Adherence by Combining the Test of Adherence to Inhalers With Pharmacy Refill Records.
    J Investig Allergol Clin Immunol. 2021;31:58-64.
    PubMed         Abstract available

  36. MIRALLES LOPEZ JC, Escudero Pastor AI, Carbonell Martinez A, Navarro Garrido C, et al
    Benralizumab in Real Life.
    J Investig Allergol Clin Immunol. 2021;31:87-88.

  37. DELGADO J, Davila IJ, Dominguez-Ortega J
    Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement.
    J Investig Allergol Clin Immunol. 2021;31:36-43.
    PubMed         Abstract available


  38. WALTER K
    Mechanical Ventilation.
    JAMA. 2021;326:1452.

    N Engl J Med

  39. BARDIN PG, Foster PS
    Clinical Translation of Basic Science in Asthma.
    N Engl J Med. 2021;385:1714-1717.

  40. BRIGHTLING CE, Nair P, Cousins DJ, Louis R, et al
    Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled Trial.
    N Engl J Med. 2021;385:1669-1679.
    PubMed         Abstract available

  41. WECHSLER ME, Ruddy MK, Pavord ID, Israel E, et al
    Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma.
    N Engl J Med. 2021;385:1656-1668.
    PubMed         Abstract available

    Pediatr Pulmonol

  42. ROSS MK, Friedman S, Radparvar I, Ryan G, et al
    Partnered decision support: Parental perspectives of completing a pre-visit pediatric asthma questionnaire via the patient portal.
    Pediatr Pulmonol. 2021 Oct 21. doi: 10.1002/ppul.25735.
    PubMed         Abstract available

  43. YANG Z, Wang X, Wan XG, Wang ML, et al
    Pediatric asthma control during the COVID-19 pandemic: a systematic review and meta-analysis.
    Pediatr Pulmonol. 2021 Oct 21. doi: 10.1002/ppul.25736.
    PubMed         Abstract available

  44. RIZZARDI KF, Toledo EDS, Ferraz LFC, Darrieux M, et al
    Association between asthma and enamel defects in primary and young permanent teeth - a systematic review.
    Pediatr Pulmonol. 2021 Oct 26. doi: 10.1002/ppul.25737.
    PubMed         Abstract available

    PLoS One

  45. NACERADSKA M, Pekova S, Danesi P, Furlanello T, et al
    A novel Filobacterium sp can cause chronic bronchitis in cats.
    PLoS One. 2021;16:e0251968.
    PubMed         Abstract available

  46. ABDUR REHMAN N, Counts S
    Neighborhood level chronic respiratory disease prevalence estimation using search query data.
    PLoS One. 2021;16:e0252383.
    PubMed         Abstract available

  47. LAUNAY T, Souty C, Vilcu AM, Turbelin C, et al
    Common communicable diseases in the general population in France during the COVID-19 pandemic.
    PLoS One. 2021;16:e0258391.
    PubMed         Abstract available

  48. LEE J, Lee SH, Gu GJ, Choi JH, et al
    Alterations of lung microbial communities in obese allergic asthma and metabolic potential.
    PLoS One. 2021;16:e0256848.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  49. DUTTA J, Rehman R, Vellarikkal SK, Fredenburgh LE, et al
    Possible selection bias limits the interpretation of single-cell transcriptomics data of steroid-resistant asthma exacerbation.
    Proc Natl Acad Sci U S A. 2021;118.

    Respir Med

  50. OLIVEIRA CC, Annoni R, Lee AL, McGinley J, et al
    Falls prevalence and risk factors in people with chronic obstructive pulmonary disease: A systematic review.
    Respir Med. 2021;176:106284.
    PubMed         Abstract available

  51. KEOGH E, Mark Williams E
    Managing malnutrition in COPD: A review.
    Respir Med. 2021;176:106248.
    PubMed         Abstract available

  52. TIOTIU A, Ioan I, Poussel M, Schweitzer C, et al
    Comparative analysis between available challenge tests in the hyperventilation syndrome.
    Respir Med. 2021;179:106329.
    PubMed         Abstract available

  53. VERBERKT CA, van den Beuken-van Everdingen MHJ, Dirksen CD, Schols JMGA, et al
    Cost-effectiveness of sustained-release morphine for refractory breathlessness in COPD: A randomized clinical trial.
    Respir Med. 2021;179:106330.
    PubMed         Abstract available

  54. YANGUI F, Touil A, Antit S, Zakhama L, et al
    COPD prevalence in smokers with stable ischemic heart disease: A cross-sectional study in Tunisia.
    Respir Med. 2021;179:106335.
    PubMed         Abstract available

  55. PINI L, Giordani J, Gardini G, Concoreggi C, et al
    Emergency department admission and hospitalization for COPD exacerbation and particulate matter short-term exposure in Brescia, a highly polluted town in northern Italy.
    Respir Med. 2021;179:106334.
    PubMed         Abstract available

  56. KOHLBRENNER D, Clarenbach CF, Thiel S, Roeder M, et al
    A few more steps lead to improvements in endothelial function in severe and very severe COPD.
    Respir Med. 2021;176:106246.
    PubMed         Abstract available

  57. ZAIGHAM S, Dencker M, Karlsson MK, Thorsson O, et al
    Lung function is associated with tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in school-aged children.
    Respir Med. 2021;176:106235.
    PubMed         Abstract available

  58. ZELL-BARAN LM, Krefft SD, Moore CM, Wolff J, et al
    Multiple breath washout: A noninvasive tool for identifying lung disease in symptomatic military deployers.
    Respir Med. 2021;176:106281.
    PubMed         Abstract available

  59. FRANCE G, Orme MW, Greening NJ, Steiner MC, et al
    Cognitive function following pulmonary rehabilitation and post-discharge recovery from exacerbation in people with COPD.
    Respir Med. 2021;176:106249.
    PubMed         Abstract available

  60. BJERRUM AS, Skjold T, Schmid JM
    Oral corticosteroid sparing effects of anti-IL5/ anti-IL5 receptor treatment after 2 years of treatment.
    Respir Med. 2021;176:106260.
    PubMed         Abstract available

  61. BAHA A, Kokturk N
    Physician's attitude against COPD guidelines and the choice of first-line treatment for COPD.
    Respir Med. 2021;176:106273.
    PubMed         Abstract available

  62. LOPEZ-PINTOR E, Grau J, Gonzalez I, Bernal-Soriano MC, et al
    Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies.
    Respir Med. 2021;176:106280.
    PubMed         Abstract available

    Respir Res

  63. GALDI F, Pedone C, McGee CA, George M, et al
    Inhaled high molecular weight hyaluronan ameliorates respiratory failure in acute COPD exacerbation: a pilot study.
    Respir Res. 2021;22:30.
    PubMed         Abstract available

  64. CALLE RUBIO M, Rodriguez Hermosa JL, de Torres JP, Marin JM, et al
    COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort.
    Respir Res. 2021;22:36.
    PubMed         Abstract available

  65. SONG Q, Chen P, Liu XM
    The role of cigarette smoke-induced pulmonary vascular endothelial cell apoptosis in COPD.
    Respir Res. 2021;22:39.
    PubMed         Abstract available

  66. KIM J, Kim B, Bak SH, Oh YM, et al
    A comparative study of chest CT findings regarding the effects of regional dust exposure on patients with COPD living in urban areas and rural areas near cement plants.
    Respir Res. 2021;22:43.
    PubMed         Abstract available

  67. VAN DEN BERG MPM, Nijboer-Brinksma S, Bos IST, van den Berge M, et al
    The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs.
    Respir Res. 2021;22:48.
    PubMed         Abstract available

  68. KANG J, Lee JS, Lee SW, Lee JB, et al
    Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV1 level: a patient-level pooled analysis of phase-3 randomized clinical trials.
    Respir Res. 2021;22:55.
    PubMed         Abstract available

  69. SAVRAN O, Godtfredsen N, Sorensen T, Jensen C, et al
    COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
    Respir Res. 2021;22:54.
    PubMed         Abstract available

  70. TUPPER OD, Ulrik CS
    Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma.
    Respir Res. 2021;22:269.
    PubMed         Abstract available

  71. HARDING JN, Gross M, Patel V, Potter S, et al
    Association between particulate matter containing EPFRs and neutrophilic asthma through AhR and Th17.
    Respir Res. 2021;22:275.
    PubMed         Abstract available

  72. WANG Y, Liao K, Liu B, Niu C, et al
    GITRL on dendritic cells aggravates house dust mite-induced airway inflammation and airway hyperresponsiveness by modulating CD4(+) T cell differentiation.
    Respir Res. 2021;22:46.
    PubMed         Abstract available

    Rev Mal Respir

  73. GAUTIER C, Lecam MT, Basses S, Pairon JC, et al
    [A definition of work-related asthma and its social and occupational consequences in adults and teenagers].
    Rev Mal Respir. 2021 Oct 25. pii: S0761-8425(21)00367.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.